Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors

Nuclear Medicine and Biology

Volumn 41, Issue 3, 2014, Pages 282-289

  Buckway, Brandon ^a   Frazier, Nick ^a,b   Gormley, Adam J ^a,b   Ray, Abhijit ^a,c   Ghandehari, Hamidreza ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b University of Utah   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

111In; 90Y; HPMA; Hyperthermia; Radiotherapy; SPECT imaging

Indexed keywords

(111)IN; (90)Y; HPMA; HYPERTHERMIA; RADIOTHERAPY; SPECT IMAGING;

ACRYLAMIDES; ANIMALS; CELL LINE, TUMOR; FEMALE; GOLD; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; HYPERTHERMIA, INDUCED; MALE; MICE; NANOTUBES; PROSTATIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YTTRIUM RADIOISOTOPES;

EID: 84893899796     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.12.002     Document Type: Article

References (33)

1. American Cancer Society Cancer facts and figures 2012 2012, American Cancer Society, Atlanta, GA.
2. Noguchi Y., Wu J., Duncan R., Strohalm J., Ulbrich K., Akaike T., et al. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res 1998, 89:307-314.
3. Maeda H., Bharate G.Y., Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 2009, 71:409-419.
4. Maeda H., Sawa T., Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001, 74:47-61.
5. Kramer-Marek G., Capala J. The role of nuclear medicine in modern therapy of cancer. Tumour Biol 2012, 33:629-640.
6. Goldsmith S.J. Radioimmunotherapy of lymphoma: Bexxar and Zevalin. Semin Nucl Med 2010, 40:122-135.
7. Kopecek J. Polymer-drug conjugates: origins, progress to date and future directions. Adv Drug Deliv Rev 2013, 65:49-59.
8. Kopecek J., Kopeckova P., Minko T., Lu Z. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur J Pharm Biopharm 2000, 50:61-81.
9. Lu Z.R. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man. Adv Drug Deliv Rev 2010, 62:246-257.
10. Kopecek J., Kopeckova P. HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev 2010, 62:122-149.
11. Mitra A., Nan A., Line B.R., Ghandehari H. Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr Pharm Des 2006, 12:4729-4749.
12. Pike D.B., Ghandehari H. HPMA copolymer-cyclic RGD conjugates for tumor targeting. Adv Drug Deliv Rev 2010, 62:167-183.
13. Lammers T., Kiessling F., Hennink W.E., Storm G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release 2012, 161:175-187.
14. Gormley A.J., Larson N., Banisadr A., Robinson R., Frazier N., Ray A., et al. Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers. J Control Release 2013, 166:130-138.
15. Gormley A.J., Larson N., Sadekar S., Robinson R., Ray A., Ghandehari H. Guided delivery of polymer therapeutics using plasmonic photothermal therapy. Nano Today 2012, 7:158-167.
16. Larson N., Gormley A.J., Frazier N., Ghandehari H. Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia. J Control Release 2013, 170:41-50.
17. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Laser Med Sci 2008, 23:217-228.
18. Alberini J.L., Edeline V., Giraudet A.L., Champion L., Paulmier B., Madar O., et al. Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer. J Surg Oncol 2011, 103:602-606.
19. Weissleder R. Molecular imaging: principles and practice 2010, Shelton, CT, People's Medical Pub. House-USA.
20. Strohalm J., Kopecek J. Poly N-(2-hydroxypropyl) methacrylamide: 4. Heterogenous polymerization. Angew Makromol Chem 1978, 70:109-118.
21. Zarabi B., Borgman M.P., Zhuo J., Gullapalli R., Ghandehari H. Noninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging. Pharm Res 2009, 26:1121-1129.
22. Kukis D.L., DeNardo S.J., DeNardo G.L., O'Donnell R.T., Meares C.F. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates. J Nucl Med 1998, 39:2105-2110.
23. Mitra A., Nan A., Papadimitriou J.C., Ghandehari H., Line B.R. Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapy. Nucl Med Biol 2006, 33:43-52.
24. Nikoobakht B., Burda C., Braun M., Hun M., El-Sayed M.A. The quenching of CdSe quantum dots photoluminescence by gold nanoparticles in solution. Photochem Photobiol 2002, 75:591-597.
25. Liu S., Pietryka J., Ellars C.E., Edwards D.S. Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for (90)Y- and (111)In-labeled DOTA-biomolecule conjugates. Bioconjug Chem 2002, 13:902-913.
26. Biersack H.J. Clinical nuclear medicine 2007, Springer, Berlin; New York.
27. Goffredo V., Paradiso A., Ranieri G., Gadaleta C.D. Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009). Crit Rev Oncol Hematol 2011, 80:393-410.
28. Griffin R.J., Dings R.P., Jamshidi-Parsian A., Song C.W. Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia 2010, 26:256-263.
29. Song C.W., Park H.J., Lee C.K., Griffin R. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005, 21:761-767.
30. Huang J., Chunta J.L., Amin M., Lee D.Y., Grills I.S., Wong C.Y., et al. Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging. Int J Radiat Oncol Biol Phys 2012, 84:485-491.
31. Stone H.B., Coleman C.N., Anscher M.S., McBride W.H. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003, 4:529-536.
32. Zhang R., Luo K., Yang J., Sima M., Sun Y., Janat-Amsbury M.M., et al. Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel. J Control Release 2013, 166:66-74.
33. Sanches P.G., Grull H., Steinbach O.C. See, reach, treat: ultrasound-triggered image-guided drug delivery. Ther Deliv 2011, 2:919-934.